Coronavirus: dermatology update
In response to the coronavirus (COVID-19) outbreak, please read our advice and information.
The immunobullous service cares for patients with complex dermatology problems, particularly those with rare blistering diseases such as pemphigus and pemphigoid.
Although previously often life threatening, these disorders now respond to treatment much better.
Patients are seen in our weekly clinic and are managed in outpatient, day case and inpatient settings.
The clinic runs in close liaison with our specialised diagnostic laboratory and is the leading centre for the management of these disorders in the UK.
We have an active research programme, focused on better understanding the cause of autoimmune blistering disease, diagnosis and new treatments. Recent work in patients with pemphigus has defined factors that influence prognosis and identified novel genetic risk factors.